Last $8.15 USD
Change Today -0.08 / -0.97%
Volume 416.1K
OSUR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

orasure technologies inc (OSUR) Snapshot

Open
$8.25
Previous Close
$8.23
Day High
$8.31
Day Low
$7.95
52 Week High
06/20/14 - $9.00
52 Week Low
08/7/13 - $4.17
Market Cap
455.1M
Average Volume 10 Days
479.6K
EPS TTM
$-0.20
Shares Outstanding
55.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORASURE TECHNOLOGIES INC (OSUR)

orasure technologies inc (OSUR) Related Businessweek News

No Related Businessweek News Found

orasure technologies inc (OSUR) Details

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies. It also offers other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The company’s principal products comprise OraQuick ADVANCE HIV-1/2, OraQuick In-Home HIV Test, OraQuick HCV, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene DISCOVER, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, HEMAgen BUFFY COAT, PrepIT L2P, Intercept, MICRO-PLATE DOA Assays, Homogeneous DOA Assays, and professional and over-the-counter Cryosurgical Systems. In addition, it manufactures and sell oral fluid collection devices used to collect, stabilize, and store samples of genetic material for molecular testing in the clinical genetic testing, academic research, pharmacogenomics, personalized medicine, and animal genetics markets. Further, the company offers medical devices used for the removal of benign skin lesions by cryosurgery or freezing; certain immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and the FDA 510(k) cleared Q.E.D. rapid point-of-care saliva alcohol test. OraSure Technologies, Inc. sells its products to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians’ offices, and commercial and industrial entities in the United States and internationally. The company was founded in 1979 and is based in Bethlehem, Pennsylvania.

293 Employees
Last Reported Date: 03/14/14
Founded in 1979

orasure technologies inc (OSUR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $563.4K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $442.5K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $319.7K
Executive Vice President of Marketing and Sal...
Total Annual Compensation: $362.0K
Compensation as of Fiscal Year 2013.

orasure technologies inc (OSUR) Key Developments

OraSure Technologies, Inc. Revises Earnings Guidance for the Second Quarter of 2014

OraSure Technologies, Inc. revised earnings guidance for the second quarter of 2014. As a result of the $5.5 million payment expected from Roche Diagnostics, the company is reaffirming its projected range of consolidated net revenues of $26.0 to $26.5 million and is now projecting consolidated net income of approximately $0.01 to $0.02 per share for the second quarter of 2014.

OraSure Technologies, Inc. Revises Earnings Guidance for the Second Quarter of 2014

OraSure Technologies, Inc. revised earnings guidance for the second quarter of 2014. For the quarter, the company now expects consolidated net revenues of between $26.0 million and $26.5 million, and a consolidated net loss in the range of $0.08 to $0.09 per share for the second quarter.

OraSure Technologies, Inc. - Shareholder/Analyst Call

To provide an update on certain developments related to its OraQuick(R) HCV business

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSUR:US $8.15 USD -0.08

OSUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Momenta Pharmaceuticals Inc $10.71 USD +0.07
Nymox Pharmaceutical Corp $5.01 USD +0.06
Quidel Corp $23.82 USD -0.05
SciClone Pharmaceuticals Inc $4.84 USD +0.02
Trinity Biotech PLC $22.99 USD -0.24
View Industry Companies
 

Industry Analysis

OSUR

Industry Average

Valuation OSUR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.5x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORASURE TECHNOLOGIES INC, please visit www.orasure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.